Want to see AU:ALQ full AI Analyst Report?
ALS (ALQ) AI Stock Analysis
ALS
(ASX:ALQ)
The score is supported primarily by solid underlying financial performance (steady growth, durable operating margins, and improved leverage), but is held back by an expensive valuation (high P/E with modest yield) and a neutral-to-soft technical setup with limited trend momentum.
ALS (ALQ) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 7.87B
- Dividend Yield
- 2.03%
- Average Volume (3M)
- 1.43M
- Price to Earnings (P/E)
- 33.2
- Beta (1Y)
- 1.46
- Revenue Growth
- 10.69%
- EPS Growth
- 19.77%
- Country
- Australia
- Employees
- 23,342
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Consulting Services
ALS Business Overview & Revenue Model
Company Description
ALS Limited delivers expert technical services globally, specializing in analytical testing, precise measurement, and comprehensive inspection across various sectors. Its operations span continents, encompassing Africa, Asia-Pacific, Europe, the Midd...
ALS Financial Statement Overview
Summary
Steady revenue growth into 2026 and resilient operating profitability (EBIT margin improving to ~17.6% and EBITDA margin in the mid‑20% range). Leverage improved materially by 2026 (debt-to-equity down to ~0.92x) and cash flow remains positive, but the sharp 2024 net margin drop and uneven cash conversion (FCF ~47% of net income in 2026) reduce confidence.
Income Statement
78PositiveBalance Sheet
70PositiveCash Flow
74Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.32B | 3.32B | 3.00B | 2.46B | 2.28B | 1.95B |
| Gross Profit | 566.30M | 1.04B | 2.69B | 2.19B | 828.60M | 693.90M |
| EBITDA | 789.50M | 836.30M | 675.00M | 641.40M | 591.30M | 439.10M |
| Net Income | 318.70M | 318.70M | 256.20M | 12.90M | 291.20M | 190.50M |
Balance Sheet | ||||||
| Total Assets | 3.97B | 3.97B | 4.06B | 3.70B | 3.33B | 2.84B |
| Cash, Cash Equivalents and Short-Term Investments | 149.70M | 149.70M | 268.00M | 299.90M | 179.60M | 122.80M |
| Total Debt | 1.57B | 1.57B | 2.09B | 1.87B | 1.45B | 1.24B |
| Total Liabilities | 2.26B | 2.26B | 2.77B | 2.50B | 1.95B | 1.71B |
| Stockholders Equity | 1.70B | 1.70B | 1.28B | 1.18B | 1.37B | 1.12B |
Cash Flow | ||||||
| Free Cash Flow | 231.50M | 231.50M | 244.60M | 198.40M | 293.80M | 167.90M |
| Operating Cash Flow | 494.50M | 494.50M | 409.60M | 350.10M | 439.90M | 286.80M |
| Investing Cash Flow | -261.00M | -261.00M | -327.70M | -226.80M | -267.00M | -405.90M |
| Financing Cash Flow | -338.70M | -338.70M | -120.00M | -3.10M | -121.20M | 77.40M |
ALS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ALQ, the sentiment is Negative. The current price of 20.89 is above the 20-day moving average (MA) of 20.38, below the 50-day MA of 21.03, and below the 200-day MA of 22.20, indicating a neutral trend. The MACD of -0.15 indicates Negative momentum. The RSI at 54.87 is Neutral, neither overbought nor oversold. The STOCH value of 88.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ALQ.
ALS Peers Comparison
Overall Rating
AU:IMD72Outperform
AU:MND72Outperform
AU:NWH70Outperform
AU:VNT65Neutral- AU:ALQ62Neutral
AU:DOW55Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:IMD | 72Outperform | AUD 1.70B | 21.63 | 11.89% | 1.05% | 20.56% | 43.97% |
| AU:MND | 72Outperform | AUD 2.96B | 23.16 | 22.77% | 3.67% | 29.43% | 50.05% |
| AU:NWH | 70Outperform | AUD 2.91B | 18.53 | 23.03% | 3.65% | 31.39% | 451.49% |
| AU:VNT | 65Neutral | AUD 4.77B | 17.73 | 48.18% | 4.15% | -1.03% | 8.70% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| AU:ALQ | 62Neutral | AUD 10.60B | 33.16 | 18.86% | 2.03% | 10.69% | 19.77% |
| AU:DOW | 55Neutral | AUD 4.65B | 21.64 | 11.01% | 4.09% | -7.37% | 59.81% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:ALQ | ALS Ltd. | 20.89 | -0.57 | -2.65% | |
| AU:DOW | Downer EDI Limited | 7.14 | -0.27 | -3.58% | |
| AU:IMD | Imdex Ltd | 3.27 | -0.15 | -4.30% | |
| AU:MND | Monadelphous Group Limited | 29.41 | 7.28 | 32.89% | |
| AU:NWH | NRW Holdings Limited | 6.30 | 1.64 | 35.22% | |
| AU:VNT | Ventia Services Group Limited | 5.85 | 0.49 | 9.24% |
ALS Corporate Events
ALS Issues New Unquoted Equity Rights Under Employee Incentive Schemes
ALS Limited has notified the market of new unquoted equity securities issued under its employee incentive schemes, comprising 49,165 performance rights and 24,454 service rights. These instruments, referenced under ASX codes ALQAA and ALQAB, are sche...
ALS Limited Reports Lapse of Performance Rights
ALS Limited has notified the market of changes to its issued capital following the lapse of certain performance-based securities. The announcement reflects the company’s ongoing compliance with ASX disclosure rules and highlights the role of pe...
ALS reveals BlackRock Group no longer a substantial shareholder
ALS Ltd has disclosed that the BlackRock Group, comprising BlackRock Inc. and specified subsidiaries, has ceased to be a substantial holder in the company, in line with Australian Corporations Act requirements. The notice records changes in relevant...
BlackRock Group Ceases to Be Substantial Shareholder in ALS Ltd
BlackRock Group has lodged a formal notice indicating it has ceased to be a substantial shareholder in ALS Ltd, under the substantial holding provisions of the Corporations Act 2001. The change in BlackRock’s relevant interest reduces the prese...
Macquarie Group Ceases to Be Substantial Holder in ALS Limited
Macquarie Group Limited and its controlled entities have lodged a notice that they have ceased to be substantial holders in ALS Limited, indicating their voting interest in the company has fallen below the substantial holding threshold. The change, f...
Macquarie Group exits substantial holder position in ALS Limited
Macquarie Group Limited and its controlled entities have lodged a notice stating they have ceased to be substantial shareholders in ALS Limited, indicating their voting interest has fallen below the substantial holding threshold. The change, formalis...
ALS director Christina Boyce increases indirect shareholding
ALS Limited has disclosed a change in the indirect shareholding of director Christina Boyce, in line with ASX listing rule 3.19A.2 and related corporate reporting obligations. The notice reflects the company’s ongoing adherence to transparency...
ALS Corrects Disclosure on Director’s Indirect Shareholding
ALS Limited has corrected a recent disclosure relating to director Christina Boyce’s shareholding, clarifying that 2,000 ordinary shares acquired on 21 August 2026 are held indirectly through CVF Australia Pty Ltd as trustee for the MAR Family...
ALS Director Christina Boyce Acquires 2,000 ALS Limited Shares On-Market
ALS Limited has reported a change in the shareholdings of director Christina Boyce, reflecting ongoing governance and disclosure practices within the ASX-listed testing and inspection group. The company continues to operate under strict reporting obl...
ALS CEO sells shares to cover tax on incentive awards
ALS Limited has disclosed that its Managing Director and CEO, Malcolm Deane, has sold 60,944 ordinary shares in the company to meet personal tax obligations linked to awards under its Long Term Incentive Plan and Short Term Incentive Deferral Plan. T...
ALS Director Malcolm Deane Receives New Performance Rights Under 2026 LTI Plan
ALS Limited has disclosed a change in the interests of director Malcolm Deane, reflecting the grant of additional equity-based incentives under the company’s long-term incentive framework. Deane received 123,270 new performance rights under the...
ALS Issues New Unquoted Equity Rights Under Employee Incentive Scheme
ALS Limited has notified the market of the issue of unquoted equity securities under its employee incentive schemes, comprising 724,836 performance rights and 44,656 service rights. The rights were granted on July 28, 2026, and are not intended to be...
ALS Limited Announces Resignation of Long-Serving Non-Executive Director
ALS Limited has announced the resignation of Non-Executive Director John Mulcahy, effective 28 July 2026 following the company’s Annual General Meeting. Mulcahy, who joined the board in 2012, has been recognised by the board for his leadership,...
ALS shareholders back all resolutions at 2026 AGM
ALS Limited has reported the formal results of its 2026 Annual General Meeting, confirming that all resolutions put to shareholders were carried on a poll. The meeting outcomes included the adoption of the remuneration report, the election and re-ele...
ALS Targets Safety Leadership and Digital “Smart Labs” to Drive Record Performance
ALS Limited is a global testing, inspection and certification provider, delivering laboratory-based analytical services to clients across a range of industries. The company targets operational excellence and technology-led innovation, using digital t...
ALS Delivers Record FY26 Results and Accelerates Global Lab Expansion
ALS Limited reported a record FY26 financial performance, achieving its previously set FY27 financial target a year early amid geopolitical uncertainty. The group’s underlying NPAT rose 25.8% to $381.2 million, revenue increased 10.7%, and EBIT...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 19, 2026